Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Hallmarks of aging: middle-aging hypovascularity, tissue perfusion and nitric oxide perspective on healthspan
Teow J. Phua
Frontiers in Aging (2025) Vol. 5
Open Access
Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2
Mohamed Raafat, Amr Kamel, Alaa H. Shehata, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 130-130
Open Access | Times Cited: 20
Advances in localized prostate cancer: a special focus on photothermal therapy
Sara Pinho, João M. P. Coelho, Maria Manuela Gaspar, et al.
European Journal of Pharmacology (2024), pp. 176982-176982
Open Access | Times Cited: 3
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
Davide Vecchiotti, Daniela Verzella, Mauro Di Vito Nolfi, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2118-2118
Open Access | Times Cited: 12
Multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer
Ankaj Kumar, Sumedh Bahadure, Sudarshan Naidu Chilamakuri, et al.
Elsevier eBooks (2024), pp. 81-111
Closed Access | Times Cited: 1
Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia
Raman Krishnamoorthi, Anand Ganapathy A, Vijayakumari Mahadevan Hari Priya, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118207-118207
Closed Access | Times Cited: 1
Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma
Khalid Ahmed, Alisalman Sheikh, Saira Fatima, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Intermittent Fasting Protects Against Age-Induced Rat Benign Prostatic Hyperplasia via Preservation of Prostatic Histomorphology, Modification of Oxidative Stress, and Beclin-1/P62 Pathway
Nashwa Fathy Gamal El‐Tahawy, Rehab Ahmed Rifaai
Microscopy and Microanalysis (2023) Vol. 29, Iss. 3, pp. 1267-1276
Closed Access | Times Cited: 4
Ejaculation Frequency and Prostate Cancer: CAPLIFE Study
Macarena Lozano‐Lorca, Rocío Olmedo‐Requena, Rocío Barrios‐Rodríguez, et al.
The World Journal of Men s Health (2023) Vol. 41, Iss. 3, pp. 724-724
Open Access | Times Cited: 3
Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
Teow J. Phua
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 3
Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
Mohammed Ridha Jawad, Ghaith Ali Jasim
Al Mustansiriyah Journal of Pharmaceutical Sciences (2023) Vol. 23, Iss. 2, pp. 196-213
Open Access | Times Cited: 2
Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2‐ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE‐UERJ
Raphaela dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, et al.
The Prostate (2023) Vol. 84, Iss. 2, pp. 166-176
Closed Access | Times Cited: 2
Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Benign Prostatic Hyperplasia
Ming Li, Daming Xu, Shubin Lin, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 6951-6959
Open Access | Times Cited: 5
11. NGHIÊN CỨU KẾT QUẢ ĐIỀU TRỊ TĂNG SINH LÀNH TÍNH TUYẾN TIỀN LIỆT TẠI BỆNH VIỆN PHỤC HỒI CHỨC NĂNG TRUNG ƯƠNG TỪ 2022 ĐẾN 2023
Lê Ngọc Hải
Tạp chí Y học Cộng đồng (2024) Vol. 65, Iss. CD4
Open Access
Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer
Jubilee Andrew, Amanda-Lee Ezra-Manicum, Bwalya A. Witika
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access
Hypertrophie bénigne de la prostate, de la physiopathologie aux traitements
Pascal Coudert
Actualités Pharmaceutiques (2024) Vol. 63, Iss. 640, pp. 28-32
Closed Access
Prevalence of clinical symptoms and their effect on quality of life among patients with benign prostatic hyperplasia at a tertiary health facility in Minna, North central Nigeria
Florence Adule Nnatsu, Paul Otor Onah
Nigerian Journal of Pharmacy (2024) Vol. 58, Iss. 2, pp. 196-212
Closed Access
Emerging Therapeutic Frontiers in Prostate Health: Novel Molecular Targets and Classical Pathways in comparison with BPH and Prostate Cancer
Muhammad Sajjad Hassan, Hafiz Muhammad Irfan, Alamgeer, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104590-104590
Closed Access
Role of Uroflowmetry in Patients of Benign Prostatic Hyperplasia Presenting with Lower Urinary Tract Symptoms
Aijaz Hussain Memon, Mumtaz Ali Chandio, Zahoor Hussain Bhellar, et al.
Pakistan Journal of Health Sciences (2024), pp. 40-45
Closed Access
Combined ethanol extract of Hypselodelphys poggeana and Spermacoce radiata leaves ameliorate benign prostatic hyperplasia in rats via modulation of serum sex hormonal levels
Robert Ikechukwu Uroko, Solomon Nnah Ijioma, ELISHA UKO OGWO, et al.
Journal of Research in Pharmacy (2022) Vol. 26(4), Iss. 26(4), pp. 742-752
Open Access | Times Cited: 3
Comparative Study of Genomic DNA Extraction Protocols from Whole Blood for P53 Gene Polymorphism in Persons with and without Prostate Cancer
Zaizafoone N. Nasif
Baghdad Science Journal (2023) Vol. 21, Iss. 3, pp. 0975-0975
Open Access | Times Cited: 1
Evaluation of testosterone replacement therapy in the rehabilitation of men with urinary disorders after BPH surgical treatment.
В. А. Дударев, V. Yu. Startsev, N.P. Kushnirenko
Experimental and Сlinical Urology (2023) Vol. 16, Iss. 1, pp. 138-147
Open Access
Nanomedicines in Treatment of Cancer
Bushra Akhtar, Ayesha Tanveer, Ali Sharif, et al.
Learning materials in biosciences (2023), pp. 183-211
Closed Access
Combined ethanol extract of Hypselodelphys poggeana and Spermacoce radiata leaves ameliorate benign prostatic hyperplasia in rats via modulation of serum sex hormonal levels
Robert Ikechukwu Uroko, Solomon Nnah Ijioma, ELISHA UKO OGWO, et al.
Journal of Research in Pharmacy (2022) Vol. 26(4), Iss. 26(4), pp. 742-753
Open Access
Relationship between serum indirect bilirubin and prostate volume in patients with benign prostatic hyperplasia: a cross-sectional study
Cunbao Ling, Xingyu Wu, Wei Huang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 20, pp. 1127-1127
Open Access
Page 1

Scroll to top